Protein Kinase C-Dependent Dephosphorylation of Tyrosine Hydroxylase Requires the B56δ Heterotrimeric Form of Protein Phosphatase 2A by Ahn, Jung-Hyuck et al.
Protein Kinase C-Dependent Dephosphorylation of
Tyrosine Hydroxylase Requires the B56d Heterotrimeric
Form of Protein Phosphatase 2A
Jung-Hyuck Ahn
1*, Yong Kim
2, Hee-Sun Kim
3, Paul Greengard
2, Angus C. Nairn
2,4*
1Department of Biochemistry, Ewha Womans University School of Medicine, Seoul, Korea, 2Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University,
New York, New York, United States of America, 3Department of Molecular Medicine and Tissue Injury Defense Research Center, Ewha Womans University, School of
Medicine, Seoul, Korea, 4Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America
Abstract
Tyrosine hydroxylase, which plays a critical role in regulation of dopamine synthesis, is known to be controlled by
phosphorylation at several critical sites. One of these sites, Ser40, is phosphorylated by a number of protein kinases,
including protein kinase A. The major protein phosphatase that dephosphorylates Ser40 is protein phosphatase-2A (PP2A).
A recent study has also linked protein kinase C to the dephosphorylation of Ser40 [1], but the mechanism is unclear. PP2A
isoforms are comprised of catalytic, scaffold, and regulatory subunits, the regulatory B subunits being able to influence
cellular localization and substrate selection. In the current study, we find that protein kinase C is able to phosphorylate a key
regulatory site in the B56d subunit leading to activation of PP2A. In turn, activation of the B56d-containing heterotrimeric
form of PP2A is responsible for enhanced dephosphorylation of Ser40 of tyrosine hydroylase in response to stimulation of
PKC. In support of this mechanism, down-regulation of B56d expression in N27 cells using RNAi was found to increase
dopamine synthesis. Together these studies reveal molecular details of how protein kinase C is linked to reduced tyrosine
hydroxylase activity via control of PP2A, and also add to the complexity of protein kinase/protein phosphatase interactions.
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Introduction
Tyrosine hydroxylase (TH) is the rate-limiting enzyme involved
in the synthesis of catecholamines such as dopamine [2]. The
activity of TH is controlled by phosphorylation of multiple sites,
including Ser8, Ser19, Ser31 and Ser40, that is catalyzed by
several different protein kinases, including protein kinase A (PKA),
protein kinase C (PKC), calcium/calmodulin-dependent protein
kinase II (CaMKII), and the MAP kinase, ERK [3–5]. In
particular, phosphorylation of Ser40 by PKA has been found to
play a critical role in activation of TH, and has been the subject of
extensive study in dopaminergic neurons and other types of cell.
Elucidation of the mechanisms involved in control of TH is
essential for understanding its role in the normal function of
dopaminergic neurons as well as in neurodegenerative diseases
such as Parkinson’s disease, where dopamine synthesis is impaired.
The dephosphorylation of TH has also been the subject of a
number of studies. The major protein phosphatase that dephos-
phorylates Ser40 of TH is believed to be protein phosphatase 2A
(PP2A) based on in vitro studies as well as in studies in intact cell
systems using PP2A inhibitors [6–8]. A recent study has linked the
d isoform of PKC to enhanced PP2A activity and reduced TH
activity through dephosphorylation of Ser40 [1]. However, the
detailed mechanism is not known. PP2A is ubiquitously expressed
in eukaryotic cells where it exists as a heterotrimeric enzyme
composed of a 36 kDa catalytic C subunit, a 64 kDa scaffolding A
subunit, and multiple regulatory B subunits that are thought to
influence enzyme activity, substrate specificity and subcellular
localization [9–14]. We have recently found that the B56d subunit
is phosphorylated by PKA at Ser566 leading to activation of
PP2A, and enhanced dephosphorylation of certain sites in
DARPP-32 [15–16], a key mediator of dopamine action in striatal
medium spiny neurons [17]. Other recent studies suggest that the
regulation of the B56d-containing heterotrimeric form of PP2A by
PKA is not limited to medium spiny neurons and that therefore
the control of protein dephosphorylation by cAMP/PKA/B56d/
PP2A may be a more widespread phenomenon [18–20]. In the
current study, we have found that PKC phosphorylates the B56d
subunit at Ser566. Moreover, we find that the regulation of B56d
by PKC plays an important role in activation of PP2A, which in
turn is responsible for enhanced dephosphorylation of Ser40 and
inactivation of TH.
Materials and Methods
Chemicals and antibodies
Rottlerin and phorbol–12-myristate-13-acetate (PMA) were
obtained from Calbiochem (La Jolla, CA) Mouse tyrosine
hydroxylase, phospho-Ser40 and phospho-Ser31 antibodies, were
obtained from Chemicon (Temecula, CA). Anti-FLAG antibody,
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from Sigma-Aldrich (St. Louis, MO). Antibody to B56d and to the
various phosphorylation sites in B56d were prepared as described
[15]. Deuterated 2-(3,4-dihydroxyphenyl)ethyl-1,1-d2-amine HCl
(deuterated dopamine HCl) was obtained from CDN isotope INC
(Quebec, Canada).
Cell culture
Neuro-2a (N2a) cells were purchased from ATCC (Manassas,
VA), and cultured in 50% Opti-MEM and 50% DMEM
containing 10% fetal bovine serum, 50 U penicillin, and 50 mg/
ml streptomycin. N27 cells were grown in RPMI 1640 medium
with 2 mM L-glutamine, 10% fetal bovine serum, 50 U penicillin,
and 50 mg/ml streptomycin.
Transfection
N2a cells were cultured to 60–70% confluence in 50% Opti-
MEM and 50% DMEM containing 10% fetal bovine serum
without penicillin-streptomycin. Expression plasmids were trans-
fected into N2a cells in six-well plate using Fugene 6 reagent
(Roche). Media were replaced with fresh media containing 50 U
penicillin and 50 mg/ml streptomycin 12 h post-transfection.
Forty-eight hours after transfection, cells were treated with DMSO
vehicle or the indicated reagents for the indicated times. Cells were
then lysed in 200 ml of a buffer containing 50 mM Tris pH 8.0,
150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, protease inhibitor cocktail (Roche), and phosphatase
inhibitor cocktail (Calbiochem), followed by brief sonication and
centrifugation at 10,0006 g. Supernatants were used for
immunoblotting as described below.
Immunoblotting
Cell lysates were separated by 4–20%SDS-PAGE with pre-made
Tris-glycine gels (Invitrogen) and immunoblotted onto polyvinyli-
dene diflouride (PVDF) membranes (Immobilon-P; Millipore,
Bedford, Massachusetts). The membranes were blocked for 2 h at
room temperature in Superblock reagent (Pierce) and phosphatase
inhibitor cocktail (1 ml in 100 ml of blocking reagent). Membranes
were probed with the indicated antibodies. Antibody binding was
detected using horseradish peroxidase-linked IgG (1:10000; Pierce)
and the ECLimmunoblottingdetection system (GEHealthcare Life
Science). For each experiment, values for levels of phospho-proteins
were corrected for loading of total protein and then data was
calculated relative to the value for the control in each experiment.
Normalized data from multiple experiments were expressed as
means as described in the Figure legends.
Immunoprecipitation and in vitro PKC phosphorylation
assays
FLAG-B56d wt or FLAG-B56d S566A mutant were expressed
in N2a cells and active heterotrimeric complexes were immuno-
precipitated from cell lysates using anti-FLAG antibody as
described [15,21]. PKC was purified from rat brain as described
[22]. Immunoprecipitated PP2A was mixed with purified PKC
(100 ng) without (control) or with PKC activators (0.1 mg/ml
phosphatidylserine, 0.02 mg/ml diacylglycerol, 0.2 mM CaCl2)
and Mg ATP for 10 min in kinase reaction buffer (20 mM Tris-
HCl, pH 7.4, 10 mM MgCl2, 150 mM NaCl).
Viral production and purification of adeno-associated
virus-RNAi (AAV-RNAi)
B56d oligonucleotides for RNAi production, GATCCCCC-
CAGTGCTGTGTCCTCTTT CTTCCTGTCA AAAGAGGA-
CACAGCACTGGTTTTTTGGAAT and CTAGATTCCAAA-
AAACCAGTGCTGTGTCCTCTTTTGACAGGAAG AAAG-
AGGACACAGCACTGG GGG, were hybridized in buffer
[100 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 150 mM NaCl],
and then ligated into pAAV-H1 precut with Bgl II and Xba I.
HEK293 cells (ATCC, Manassas, VA) were grown in ten 150625-
mm dishes and co-transfected with pAAV-H1/B56dRNAi or
pAAV-H1 (control AAV-RNAi) and helper plasmid using calcium
phosphate. Cells were trypsinized, pelleted and resuspended in
buffer [0.15 M NaCl and 50 mM Tris-HCl (pH 8.0)] 72-hour post-
transfection. Virus was purified using a published protocol [23] with
some modifications. Briefly, after three freeze-thaw cycles (liquid
nitrogen to 37uC) to lyse the cells, benzoase was added (50 U/ml,
final) and the cell lysate was incubated at 37uC for 30 min. The
lysate was added to a centrifuge tube containing a 15%, 25%, 40%
and 60% iodixanol step gradient. Samples were centrifuged at
350,000 g for 60 min at 18uC, the 40% fraction was collected, then
added to an affinity column containing heparin type 1 (Sigma),
washed with 0.1 M NaCl and eluted with 1 M NaCl. Elution buffer
was exchanged with 25 volumes of PBS using an Amicon Ultra
100K NMWL centrifugal filter. The virus was titered using an AAV
ELISA kit (Progen) and kept at 280uC until time of use. AAV
(1610
12 pfu) was added to each well of a 6-well plate (cells were
typically 70% confluent) for 48 hours. AAV without any RNAi
oligonucleotide was used as a control.
Dopamine measurement
N27 cells expressing either control RNAi or B56d RNAi were
lysed and sonicated in 50 mM ammonium bicarbonate buffer
(pH 8.0) after 72 h. Dopamine was measured using LC-MS/MS.
Dopamine-1,1,2,2-d4 hydrochloride (CDN isotopes, Quebec,
Canada) was used as a standard. The dopamine isotope was
spiked into the samples and analyzed by nanoHPLC-MS with a
QSTAR QqTOF mass spectrometer (Applied Biosystems).
Results
The PKC activator PMA increases phosphorylation of the
B56d subunit of PP2A at Ser566
To initially address the ability of PKC to regulate the
phosphorylation of the B56d subunit, we expressed FLAG-B56d
in N2a cells, then treated cells with vehicle or the phorbol ester
PMA under a variety of conditions (Figure 1). The phosphoryla-
tion level at four sites in B56d (Ser53, Ser68, Ser81, Ser566) was
analyzed with their respective phospho-specific antibody. PMA
treatment increased the phosphorylation level of Ser566 ,1.5-fold
compared to vehicle-treated cells (Figure 1a). Exposure of N2a
cells to different concentrations of PMA resulted in a dose
responsive increase in Ser566 phosphorylation up to 10 nM
(Figure 1b). In response to treatment with PMA, phosphorylation
of B56d was rapid and maximal after 30 min (Figure 1c). In the
presence of 5 nM PMA, the phosphorylation at Ser566 increased
,3.5-fold after 30 min compared to the vehicle-treated control.
PKCd is involved in PMA-dependent phosphorylation of
B56d
We next investigated the type of PKC isozyme involved in B56d
phosphorylation. FLAG-B56d was expressed in N2a cells, and the
effect of the PKCd inhibitor rottlerin was examined (Figure 2).
Cells were pre-incubated in the absence or presence of rottlerin for
30 min, treated with DMSO vehicle or PMA. PMA-dependent
phosphorylation at Ser566 was inhibited by rottlerin. Rottlerin
alone did not have any significant effect on Ser566 phosphory-
lation. Go6976, a PKCa specific inhibitor, did not affect Ser566
PP2A-Dependent Activation of Tyrosine Hydroxylase
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shown) suggesting that PKCd is likely a major PKC isozyme
involved in B56d phosphorylation in N2a cells.
PKC activates the B56d heterotrimeric form of PP2A in
vitro via phosphorylation at Ser566
Our previous studies have shown that exogenous expression of
the B56d subunit results in formation of a heterotrimeric complex
that can be isolated from cell lysates (Ahn et al. 2007a). Wild-type
B56d (FLAG-B56d wt) or a mutant in which Ser566 was replaced
by alanine (FLAG-B56d S566A) were expressed in N2a cells, and
PP2A heterotrimers were immunoprecipitated with anti-FLAG
antibody. The immuno-purified PP2A preparations were then
incubated in vitro with PKC and MgATP in the absence or
presence of a PKC activator mixture which contained phospha-
tidylserine, diacylglycerol, and Ca
2+ (Figure 3). Using immuno-
blotting, for the PP2A preparation that contained wild-type B56a
subunit, a low level of phosphorylation at Ser566 was observed in
the presence of PKC, and this was increased with addition of the
PKC activator mixture (Figure 3A). However, as expected, only
background phospho-Ser566 signal was detected in the PP2A
preparation that contained B56d with the S566A mutation.
Figure 1. The PKC activator PMA increases phosphorylation of B56d at Ser566. (A) N2a cells expressing FLAG-B56d subunit were treated
with DMSO (vehicle) or PMA (5 nM) for 5 min. Cells were lysed and proteins were analyzed by SDS-PAGE and immunoblotting with phospho-specific
antibodies to the indicated sites in B56d. Total B56d was analyzed with anti-FLAG antibody. Upper panels show immunoblots. The bar graph shows
quantification of immunoblot data normalized in each experiment to vehicle for each site as means 6 s.e.m. (n=3). *, P,0.001 compared with
vehicle-treated control by student’s t-test. (B) N2a cells expressing FLAG-B56d were treated with different concentrations of PMA (0, 1, 10, 100,
1000 nM) for 5 min. Phosphorylation of Ser566 and total B56d was assayed as in (A). The bar graph shows quantification of data normalized in each
experiment to the zero PMA condition as means 6 s.e.m. (n=3). *, P,0.05, **, P,0.01 compared with vehicle-treated control by student’s t-test. (C)
N2a cells expressing FLAG-B56d were treated with 5 nM PMA for the indicated times. Phosphorylation of Ser566 and total B56d was assayed as in (A).
The bar graph shows quantification of data normalized in each experiment to the zero time condition as means 6 s.e.m. (n=3). *, P,0.01,
**, P,0.001 compared with vehicle treated control by student’s t-test.
doi:10.1371/journal.pone.0026292.g001
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resulted in activation of the PP2A preparation containing wild-
type B56d as measured using a synthetic phospho-peptide as
substrate. However, there was no effect of PKC on PP2A activity
associated with the B56d S566A mutant. We also carried out
assays where ATP was replaced by [
32P] ATP. Phosphorylation of
the A, B and C subunits was detected in the absence of the PKC
activator mixture, while addition of the activator mixture led to
increased phosphorylation of the B56d subunit, with a smaller
increase also being observed for the C subunit, and no increase
being observed for the A subunit (see supplementary Figure S1).
Mutation of Ser566 prevented the increase in phosphorylation of
the B56d mutant protein, seen in the presence of the PKC
activator mixture. However, mutation of Ser566 had no effect on
phosphorylation of either the A or C subunits. Taken together
with the phosphatase activity assays, these results indicate that
phosphorylation of Ser566 in the B56d subunit by PKC is solely
responsible for the activation of PP2A activity observed in the in
vitro assays.
PP2A containing the B56d subunit is activated by PMA,
and selectively dephosphorylates Ser40 of tyrosine
hydroxylase
Among several sites such as Ser8, Ser19, Ser31, and Ser40,
phosphorylation of Ser40 by PKA has been found previously to be
associated with increased activity of TH [5]. Interestingly, a
previous study found that PKCd was associated with activation of
PP2A and dephosphorylation of Ser40 [1], but the precise
mechanism was not elucidated. To address the role of PKC-
mediated activation of B56d in PP2A-mediated dephosphorylation
of TH, we analyzed the phosphorylation status of Ser40 of TH in
rat mesencephalic neuronal N27 cells that express significant
endogenous levels of the enzyme and which produce dopamine
following dibutyryl cAMP-induced differentiation [24]. Notably,
N27 cells expressed higher levels of B56d than N2a cells, and the
effect of PMA on B56d S566 phosphorylation was robust in N27
cells (data not shown).
N27 cells expressing either vector control, FLAG-B56d wt, or
FLAG-B56d S566A, were treated with PMA, then the phosphor-
ylation level of Ser40 of tyrosine hydroxylase was analyzed by
immunoblotting (Figure 4). In control cells (vector alone), upon
PMA stimulation the phosphorylation on Ser40 was decreased.
Expression of FLAG-B56d wt resulted in a slightly larger effect of
PMA but this was not statistically significant. In contrast, in cells
expressing FLAG-B56d S566A, there was an increased basal level
of phosphorylation of Ser40 which was unaffected by PMA.
Phosphorylation of Ser31, which was used as a control, was
unaffected by any condition examined.
These results suggest that the FLAG-B56d S566A mutant may
be acting in a dominant-negative manner to antagonize the
endogenous action of B56d. We further examined the PKC-
dependent regulation of PP2A/B56d using RNAi to down-
regulate endogenous B56d expression in N27 cells (Figure 5).
B56d-specific RNAi, expressed via adeno-associated virus (AAV)
in N27 cells, resulted in reduced expression of endogenous B56d
protein by the B56d-specific RNAi (less than 20% compared to
control RNAi). Control RNAi expression had no effect compared
to non-infected cells (not shown). Control or B56d knock-down
Figure 2. Rottlerin inhibits PMA-dependent phosphorylation of
Ser566 in B56d. N2a cells expressing FLAG-B56d were pretreated
without or with rottlerin (5 mM) for 30 min as indicated and then
treated with DMSO (Control) or PMA (10 nM) for an additional 10 min.
Phosphorylation of Ser566 and total B56d was assayed as above. The
bar graph shows quantification of immunoblot data (not shown)
normalized in each experiment to control as means 6 s.e.m. (n=3).
*, P,0.001, **, P,0.01 compared with vehicle-treated vector control by
one-way ANOVA with Newman-Keuls multiple comparison test.
doi:10.1371/journal.pone.0026292.g002
Figure 3. PKC activates PP2A/B56d in vitro. FLAG-B56d wt or
FLAG-B56d S566A mutant were expressed in N2a cells and active
heterotrimeric complexes were immunoprecipitated from cell lysates
using anti-FLAG antibody. Immunoprecipitated PP2A was mixed with
purified PKC without (control) or with PKC activators (0.1 mg/ml
phosphatidylserine, 0.02 mg/ml diacylglycerol, 0.2 mM CaCl2) and Mg
ATP for 10 min. (A). Phosphorylation at Ser566 of B56d was assessed by
immunoblotting using anti-phospho-Ser566 antibody. As a loading
control, total B56d subunit and co-immunoprecipitated PP2A C subunit
were assessed by immunoblotting. (B). Immobilized PP2A was
suspended in phosphatase assay buffer then PP2A activity was
measured using a phospho-peptide substrate (Promega, 5 min assay).
Phosphatase activity is shown as means 6 s.e.m. (n=3). *, P,0.001,
compared with no PKC activator control by student’s t-test.
doi:10.1371/journal.pone.0026292.g003
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together with rottlerin. PMA treatment resulted in dephosphor-
ylation of phospho-Ser40 in control RNAi-infected cells, and this
was inhibited by rottlerin. However, there was no effect of PMA
treatment in cells in which B56d expression was knocked down.
Notably, the basal level of phospho-Ser40 was increased following
knockdown of B56d. Phosphorylation of Ser31 was unaffected
under any of the conditions used.
PP2A containing the B56d subunit regulates dopamine
synthesis in N27 cells
Previous studies have indicated that PKCd-deficient N27 cells
showed an increase in dopamine synthesis through enhanced TH
activity [1]. We further examined the physiological role of TH
regulation by PKC-mediated control of the B56d subunit by
measuring dopamine synthesis in N27 cells (Figure 6). Expression
of B56d was knocked down in N27 cells using AAV-mediated
expression of B56d RNAi. After 72 h, cells were harvested, and
dopamine production was analyzed using LC/MS. N27 cells with
reduced B56d expression showed significantly increased dopamine
levels compared to cells expressing a control RNAi plasmid.
Dopamine levels were determined to be 1.5960.16 mg/mg of
protein in control RNAi cells compared to 3.6960.21 mg/mg
protein in B56d RNAi expressing cells.
Discussion
The results obtained in this study indicate that Ser566 in the
B56d subunit of PP2A is phosphorylated in response to activation
of PKC in intact cells. Previously we have found that
Figure 4. Phosphorylation of B56d at Ser566 mediates PMA-
dependent dephosphorylation of Ser40 of tyrosine hydroxy-
lase. N27 cells expressing either vector, FLAG-B56d wt or FLAG-B56d
S566A mutant were treated with either DMSO (-) or PMA (10 nM) for
30 min. Cells were lysed and proteins were analyzed by SDS-PAGE and
immunoblotting with phospho-specific antibodies to Ser40 and Ser31
in tyrosine hydroxylase (TH), and a total tyrosine hydroxylase antibody
(upper panels). The bar graph shows quantification of the immunoblot
data normalized in each experiment to control as means 6 s.e.m.
(n=3). *, P,0.001, **P,0.01, ***P,0.05 compared with vehicle-treated
vector control by one-way ANOVA with Newman-Keuls multiple
comparison test.
doi:10.1371/journal.pone.0026292.g004
Figure 5. PMA-dependent dephosphorylation of Ser40 in
tyrosine hyroxylase is inhibited by down-regulation of B56d.
N27 cells were infected with either AAV-control RNAi or AAV-B56d RNAi
for 48 h. N27 cells were then pretreated with either vehicle or rottlerin
(5 mM) for 30 min, then treated with PMA (10 nM) for 10 min as
indicated. Phosphorylation of Ser40 and Ser31 of tyrosine hyroxylase
was measured as above. B56d levels were measured by immunoblot-
ting. The bar graph shows quantification of immunoblot data
normalized in each experiment to control as means 6 s.e.m. (n=3).
*, P,0.001 compared with vehicle-treated control by one-way ANOVA
with Newman-Keuls multiple comparison test.
doi:10.1371/journal.pone.0026292.g005
Figure 6. Dopamine synthesis in N27 cells is increased
following down-regulation of B56d. N27 cells were infected with
AAV-control RNAi or AAV- B56d RNAi for 72 h. Dopamine was measured
in cell lysates by LC/MS with tritium labeled DA as a standard. Data are
shown as means 6 s.e.m. (n=3). *, P,0.01 compared with control RNAi
infected cells by student’s t-test.
doi:10.1371/journal.pone.0026292.g006
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phosphatase activity of the heterotrimeric PP2A complex contain-
ing B56d (Ahn et al. 2007a). Consistent with our previous results,
phosphorylation of Ser566 of B56d was accompanied by activation
of PP2A. The results obtained from studies with over-expression of
wild-type and mutant B56d, as well as of knockdown of B56d
expression, provide strong support for the conclusion that
phosphorylation of B56ds causally involved in mediating the
effect of PKC activation on dephosphorylation of Ser40 in TH.
Our results are consistent with a role for the PKCd isoform in
regulation of the B56d/PP2A heterotrimer based on the use of the
relatively specific inhibitor, rottlerin. Various studies have found
that several different isoforms of PKC are able to interact with
PP2A, although nothing appears to be known about the identity of
the B subunit in these complexes [25–28]. We therefore cannot
rule out that PKC isoforms other than PKCd might be able to
regulate PP2A activity via phosphorylation of B56d.
In previous studies, Zhang et al have shown that PKC could
enhance PP2A activity resulting in dephosphorylation of Ser40 of
TH [1]. Based on in vitro experiments, their study suggested that
PKC could phosphorylate the C subunit of PP2A, apparently
leading to increased phosphatase activity. However, the in vitro
evidence for this was not strong, and the mechanism involved in
intact cells was not studied. Our results indicate that B56d
phosphorylation at Ser566 is responsible for all of the effects we
observed of PKC activation on TH Ser40 dephosphorylation.
A number of studies have implicated PKC in the regulation of
TH in several different cellular systems [5]. However, the precise
actions of PKC have been difficult to assess. In vitro, PKC is able
to phosphorylate TH at Ser40 and stimulate its activity [29].
However, another in vitro study found that while PKC could
phosphorylate TH at Ser40, there was no effect on activity [30].
The exact reason for the differences in these studies is not clear but
may be related to the stoichiometry of phosphorylation that was
achieved in the two studies. Several studies using intact cell
preparations have indicated that activation of PKC leads to
phosphorylation and activation of TH [31–33]. Some of these
studies indicate that Ser40 is regulated by PKC while others
suggest the likelihood that Ser31 may be the site that is targeted.
Our results as well as those of Zhang et al [1] show a consistent
ability of PKC activation to result in dephosphorylation of TH at
Ser40, with no obvious effect at Ser31, in a number of different
types of cell types in culture as well as in vivo. Presumably, the
differences observed in the different studies reflect the use of
various types of cells and the methods used to stimulate PKC.
Based on our results, it is also possible that the cell types used in
these previous studies expressed variable levels of B56d, which has
been found to have restricted cell and tissue expression [34]. In the
absence of B56d, PP2A would not be activated and therefore PKC
activation might lead alternatively to phosphorylation and
activation of TH.
Our recent studies have found that PP2A is subject to novel
forms of regulation by second messenger-mediated signaling
mechanisms. We have found that cAMP/PKA can be coupled
to protein dephosphorylation via the ability of PKA to
phosphorylate B56d and activate PP2A [15]. In other studies,
we have found that Ca
2+ can activate the PR72-containing
heterotrimer of PP2A [21]. The present study extends these results
and shows that pathways traditionally thought to increase
phosphorylation can also be coupled to pathways that result in
decreased phosphorylation of selected substrates. The B subunits
of PP2A likely influence the specificity of PP2A towards certain
substrates through direct protein:protein interactions [10,35]. The
crystal structures of a PP2A heterotrimer containing the core
domain of the B56c isoform has provided important insight into
holoenzyme assembly, and the role of the B56 subunit in substrate
recognition [35–38]. The central core of the B56 subunit contains
a number of HEAT-like repeats that make multiple contacts with
the C subunit, suggesting mechanisms whereby the specificity of
substrate interactions with the active site of PP2A can be
influenced. A previous study found that the B56b isoform of
PP2A was able to confer specificity for PP2A towards Ser40 of TH
[8]. A recent follow-up study found that a specific Glu residue
(Glu153) in B56b is an important molecular determinant for PP2A
specificity towards TH [39]. Notably, a residue equivalent to
Glu153 is found in other B56 isoforms including B56d. The
precise mechanism whereby phosphorylation of Ser566 of B56d is
able to increase PP2A activity is not known. However,
phosphorylation may be able to increase PP2A affinity for TH
or other selected substrates through additional protein:protein
interactions, perhaps by influencing the interaction of Glu153 with
specific substrates like TH.
Phosphorylation of Ser40 of TH by PKA is known to play a
critical role in the regulation of enzyme activity [5]. Based on our
previous studies of regulation of B56d, one might speculate that
activation of PKA could also lead to dephosphorylation of TH at
Ser40. While we did not investigate this in detail, our preliminary
studies suggest that stimulation of PKA results in increased Ser40
phosphorylation in the cell lines used in this study. We interpret
these results and studies of TH in other cell systems as indicating
that the balance between PKA-mediated phosphorylation and
PKA/B56d/PP2A-mediated dephosphorylation favors the phos-
phorylation of Ser40 by PKA. A similar situation is found for
phosphorylation of Thr34 of DARPP-32 by PKA [15].
Our initial studies of B56d and regulation of PP2A by cAMP/
PKA-dependent signaling focused on DARPP-32, a protein that
plays an important role in dopaminergic signaling in striatal
neurons [16,17]. Other more recent studies have suggested that
this mechanism is more widespread and we have implicated its
role in regulation of PP2A in a number of different cellular
signaling processes [18–20]. By comparison, it seems likely that the
ability of PKC to regulate PP2A via phosphorylation of B56d may
also play a role in the dephosphorylation of substrates other than
TH in neuronal and non-neuronal cell types. In one study of
B56d, regulation of PP2A activity has been found to be involved in
a complex signaling process in cardiac muscle involving protein:-
protein interactions between PP2A, PKA and the muscle A kinase
anchoring protein, and the phosphodiesterase PDE4D3 [19]. This
results in both feed-forward and feed-back mechanisms that are
presumably designed to fine-tune cAMP signaling in muscle. A
number of studies have found that PP2A interacts with various
isoforms of PKC, and that in some cases PP2A is able to
dephosphorylate and inactivate certain PKC isoforms including
PKCd [40]. This suggests by analogy with the example of B56d-
dependent regulation of PDE4D3 in cardiac muscle, that PKC is
able to phosphorylate and activate PP2A, but that PP2A can
inactivate PKC through a feed-back mechanism leading to
transient control of this signaling system.
Supporting Information
Figure S1 PKC-mediated phosphorylation of PP2A with
B56d subunit. N2a cells were transfected either with FLAG-
B56d S566A mutant or FLAG- B56d wt then the lysates were
immunoprecipitated using anti-FLAG antibody. Immunoprecipi-
tated PP2A holoenzymes were eluted by adding FLAG peptide
(100 mg/ml, Sigma-Aldrich, St. Louis, MO) for 10 min. Eluted
PP2A with B56d subunit complex was incubated with purified
PP2A-Dependent Activation of Tyrosine Hydroxylase
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26292PKC and [c-
32P] ATP without or with PKC activator for 5 min.
Immune-complexes were separated with 4-20% SDS-PAGE, and
phosphorylation of PP2A subunits measured using autoradiogra-
phy. After autoradiography, bands corresponding to each subunit
(A, B, and C) were excised and
32P incorporation measured using
a scintillation counter (cpm). The bar graph represents the cpm as
means 6 s.e.m. (n=3). *, P,0.001, **P,0.01, ***P,0.05
compared with PKC-only treated control by student’s t-test.
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